What Nuvectis Pharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 5 |
| Sells | 0 | 0 |
| Total trades | 1 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 30,000 | 772,700 |
| Disposed | 0 | 0 |
| Net activity | +30,000 | +772,700 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Carson Michael J. | Vice President, Finance | Aug 03 | Grant / award · A | +30,000 | — | — | 230,118 |
| Bentsur Ron | Chairman & CEO | Jun 30 | Open-market buy · P | +12,500 | $20.00 | +$250K | 3,688,424 |
| Mosseri Marlio Charles | 10% owner | Jun 30 | Open-market buy · P | +50,000 | $18.32 | +$916K | 3,186,576 |
| Sanchez Juan | Director | Jun 11 | Grant / award · A | +35,000 | — | — | 113,380 |
| Oliviero James F Iii | Director | Jun 11 | Grant / award · A | +35,000 | — | — | 122,828 |
| Kaplan Matthew L. | Director | Jun 11 | Grant / award · A | +35,000 | — | — | 159,760 |
| Hoberman Kenneth | Director | Jun 11 | Grant / award · A | +35,000 | — | — | 168,140 |
| Shemesh Shay | Chief Dev. & Ops. Officer | Jan 06 | Grant / award · A | +150,000 | — | — | 1,793,068 |
| Poradosu Enrique | Chief Science & Business Off | Jan 06 | Grant / award · A | +150,000 | — | — | 1,806,319 |
| Carson Michael J. | Vice President, Finance | Jan 06 | Grant / award · A | +61,200 | — | — | 200,118 |
| Bentsur Ron | Chairman & CEO | Jan 06 | Grant / award · A | +150,000 | — | — | 3,675,924 |
| Sanchez Juan | Director | Nov 05 | Open-market buy · P | +13,000 | $5.79 | +$75.3K | 78,150 |
| Kaplan Matthew L. | Director | Nov 05 | Open-market buy · P | +11,000 | $5.84 | +$64.2K | 124,760 |
| Bentsur Ron | Chairman & CEO | Nov 05 | Open-market buy · P | +5,000 | $5.72 | +$28.6K | 3,525,924 |
| Mosseri Marlio Charles | 10% owner | Oct 27 | Open-market buy · P | +72,836 | $6.28 | +$457K | 3,136,576 |
| Mosseri Marlio Charles | 10% owner | Oct 24 | Open-market buy · P | +35,034 | $6.15 | +$215K | 3,063,740 |
| Mosseri Marlio Charles | 10% owner | Oct 23 | Open-market buy · P | +46,900 | $6.06 | +$284K | 3,028,706 |
| Sanchez Juan | Director | Sep 22 | Grant / award · A | +30,000 | — | — | 65,150 |
| Mosseri Marlio Charles | 10% owner | Jun 20 | Open-market buy · P | +5,603 | $7.99 | +$44.8K | 2,981,806 |
| Mosseri Marlio Charles | 10% owner | Jun 18 | Open-market buy · P | +28,043 | $8.05 | +$226K | 2,976,203 |
Loading...
